(Q39564214)

13 September 2017

Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells (English)

1 reference

evasion of host immune response

13 September 2017

1 reference

Lutao Du

1

1 reference

13 September 2017

Xiaoyan Xiao

2

1 reference

13 September 2017

Chuanxin Wang

3

1 reference

13 September 2017

Xuhua Zhang

4

1 reference

13 September 2017

Ni Zheng

5

1 reference

13 September 2017

Lili Wang

6

1 reference

13 September 2017

Xin Zhang

7

1 reference

13 September 2017

Wei Li

8

1 reference

13 September 2017

Shun Wang

9

1 reference

13 September 2017

Zhaogang Dong

10

1 reference

13 September 2017

1 June 2011

1 reference

13 September 2017

1 reference

13 September 2017

102

1 reference

13 September 2017

7

1 reference

13 September 2017

1272-1280

1 reference

Global cancer statistics, 2002

13 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

Treatment strategy of limited surgery in the treatment guidelines for gastric cancer in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

Protection from natural killer cell-mediated lysis by HLA-G expression on target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

HLA-G: a shield against inflammatory aggression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

HLA-G: from biology to clinical benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

Soluble HLA-G: Are they clinically relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

Interferons, immunity and cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

HLA-G molecules: from maternal-fetal tolerance to tissue acceptance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

A class I antigen, HLA-G, expressed in human trophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

Human leukocyte antigen-G and cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

T-regulatory cell modulation: the future of cancer immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01951.X

10.1111/J.1349-7006.2011.01951.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference